Full-length HLA-G1 and truncated HLA-G3 differentially increase HLA-E surface localization

Braud, 1998, HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C, Nature, 391, 795, 10.1038/35869 Braud, 1998, TAP- and tapasin-dependent HLA-E surface expression correlates with the binding of an MHC class I leader peptide, Curr Biol, 8, 1, 10.1016/S0960-9822(98)70014-4 Tomasec, 2000, Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40, Science, 287, 1031, 10.1126/science.287.5455.1031 Borrego, 1998, Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis, J Exp Med, 187, 813, 10.1084/jem.187.5.813 Weiss, 2009, HLA-E/human beta2-microglobulin transgenic pigs: protection against xenogeneic human anti-pig natural killer cell cytotoxicity, Transplantation, 87, 35, 10.1097/TP.0b013e318191c784 King, 2000, HLA-E is expressed on trophoblast and interacts with CD94/NKG2 receptors on decidual NK cells, Eur J Immunol, 30, 1623, 10.1002/1521-4141(200006)30:6<1623::AID-IMMU1623>3.0.CO;2-M Li, 2001, Induction of TCR Vbeta-specific CD8+ CTLs by TCR Vbeta-derived peptides bound to HLA-E, J Immunol, 167, 3800, 10.4049/jimmunol.167.7.3800 Ulbrecht, 1998, Interaction of HLA-E with peptides and the peptide transporter in vitro: implications for its function in antigen presentation, J Immunol, 160, 4375, 10.4049/jimmunol.160.9.4375 Sarantopoulos, 2004, Qa-1 restriction of CD8+ suppressor T cells, J Clin Invest, 114, 1218, 10.1172/JCI23152 Romagnani, 2002, Identification of HLA-E-specific alloreactive T lymphocytes: a cell subset that undergoes preferential expansion in mixed lymphocyte culture and displays a broad cytolytic activity against allogeneic cells, Proc Natl Acad Sci U S A, 99, 11328, 10.1073/pnas.172369799 Moreau, 2002, HLA-G protein processing and transport to the cell surface, Cell Mol Life Sci, 59, 1460, 10.1007/s00018-002-8521-8 Carosella, 1996, HLA-G revisited, Immunol Today, 17, 407, 10.1016/0167-5699(96)30055-8 Kovats, 1990, A class I antigen, HLA-G, expressed in human trophoblasts, Science, 248, 220, 10.1126/science.2326636 Wischhusen, 2007, Immune-refractory cancers and their little helpers–an extended role for immunetolerogenic MHC molecules HLA-G and HLA-E?, Semin Cancer Biol, 17, 459, 10.1016/j.semcancer.2007.07.005 Le Discorde, 2003, Expression of HLA-G in human cornea, an immune-privileged tissue, Hum Immunol, 64, 1039, 10.1016/j.humimm.2003.08.346 Donadi EA, Castelli EC, Arnaiz-Villena A, Roger M, Rey D, Moreau P: Implications of the polymorphism of HLA-G on its function, regulation, evolution and disease association. Cell Mol Life Sci 68(3):369. Rouas-Freiss, 1997, The alpha1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors?, Proc Natl Acad Sci U S A, 94, 5249, 10.1073/pnas.94.10.5249 Rouas-Freiss, 1997, Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis, Proc Natl Acad Sci U S A, 94, 11520, 10.1073/pnas.94.21.11520 Riteau, 2001, HLA-G2, -G3, and -G4 isoforms expressed as nonmature cell surface glycoproteins inhibit NK and antigen-specific CTL cytolysis, J Immunol, 166, 5018, 10.4049/jimmunol.166.8.5018 Bahri, 2006, Soluble HLA-G inhibits cell cycle progression in human alloreactive T lymphocytes, J Immunol, 176, 1331, 10.4049/jimmunol.176.3.1331 LeMaoult, 2007, Immune regulation by pretenders: cell-to-cell transfers of HLA-G make effector T cells act as regulatory cells, Blood, 109, 2040, 10.1182/blood-2006-05-024547 Caumartin, 2007, Trogocytosis-based generation of suppressive NK cells, EMBO J, 26, 1423, 10.1038/sj.emboj.7601570 Horuzsko, 2001, Maturation of antigen-presenting cells is compromised in HLA-G transgenic mice, Int Immunol, 13, 385, 10.1093/intimm/13.3.385 Riteau, 1999, HLA-G inhibits the allogeneic proliferative response, J Reprod Immunol, 43, 203, 10.1016/S0165-0378(99)00034-0 Lila, 2002, Human leukocyte antigen-G expression after heart transplantation is associated with a reduced incidence of rejection, Circulation, 105, 1949, 10.1161/01.CIR.0000015075.89984.46 Lila, 2000, Implication of HLA-G molecule in heart-graft acceptance, Lancet, 355, 2138, 10.1016/S0140-6736(00)02386-2 Rouas-Freiss, 2003, HLA-G in transplantation: a relevant molecule for inhibition of graft rejection?, Am J Transplant, 3, 11, 10.1034/j.1600-6143.2003.30103.x Sheu, 2007, Shih Ie M: Clinical and biological significance of HLA-G expression in ovarian cancer, Semin Cancer Biol, 17, 436, 10.1016/j.semcancer.2007.06.012 Ulbrecht, 2004, Truncated HLA-G isoforms are retained in the endoplasmic reticulum and insufficiently provide HLA-E ligands, Hum Immunol, 65, 200, 10.1016/j.humimm.2003.12.004 Matsunami, 2001, The possible use of HLA-G1 and G3 in the inhibition of NK cell-mediated swine endothelial cell lysis, Clin Exp Immunol, 126, 165, 10.1046/j.1365-2249.2001.01622.x Polakova, 2004, The 4H84 monoclonal antibody detecting beta2m free nonclassical HLA-G molecules also binds to free heavy chains of classical HLA class I antigens present on activated lymphocytes, Hum Immunol, 65, 157, 10.1016/j.humimm.2003.10.005 Polakova, 2003, Mild acid treatment induces cross-reactivity of 4H84 monoclonal antibody specific to nonclassical HLA-G antigen with classical HLA class I molecules, Hum Immunol, 64, 256, 10.1016/S0198-8859(02)00777-2 Wiendl, 2002, A functional role of HLA-G expression in human gliomas: an alternative strategy of immune escape, J Immunol, 168, 4772, 10.4049/jimmunol.168.9.4772 McMaster, 1998, HLA-G isoforms produced by placental cytotrophoblasts and found in amniotic fluid are due to unusual glycosylation, J Immunol, 160, 5922, 10.4049/jimmunol.160.12.5922 Ravindranath, 2009, HLA-E monoclonal antibodies recognize shared peptide sequences on classical HLA class Ia: relevance to human natural HLA antibodies, Mol Immunol, 47, 1121, 10.1016/j.molimm.2009.10.024 Chen, 2006, CD28-stimulated ERK2 phosphorylation is required for polarization of the microtubule organizing center and granules in YTS NK cells, Proc Natl Acad Sci U S A, 103, 10346, 10.1073/pnas.0604236103 Menier, 2003, Characterization of monoclonal antibodies recognizing HLA-G or HLA-E: new tools to analyze the expression of nonclassical HLA class I molecules, Hum Immunol, 64, 315, 10.1016/S0198-8859(02)00821-2 Lo Monaco, 2008, HLA-E: strong association with beta2-microglobulin and surface expression in the absence of HLA class I signal sequence-derived peptides, J Immunol, 181, 5442, 10.4049/jimmunol.181.8.5442 Lo Monaco, 2010, HLA-E and the origin of immunogenic self HLA epitopes, Mol Immunol, 47, 1661, 10.1016/j.molimm.2009.12.018 Ravindranath, 2000, HLA-E monoclonal antibodies recognize shared peptide sequences on classical HLA class Ia: relevance to human natural HLA antibodies, Mol Immunol, 47, 1121, 10.1016/j.molimm.2009.10.024 Paul, 2000, HLA-G, -E, -F preworkshop: tools and protocols for analysis of non-classical class I genes transcription and protein expression, Hum Immunol, 61, 1177, 10.1016/S0198-8859(00)00154-3 Khalil-Daher, 1999, Role of HLA-G versus HLA-E on NK function: HLA-G is able to inhibit NK cytolysis by itself, J Reprod Immunol, 43, 175, 10.1016/S0165-0378(99)00032-7 Riteau, 2001, HLA-G1 co-expression boosts the HLA class I-mediated NK lysis inhibition, Int Immunol, 13, 193, 10.1093/intimm/13.2.193 Sala, 2004, The HLA-G∗0105N null allele induces cell surface expression of HLA-E molecule and promotes CD94/NKG2A-mediated recognition in JAR choriocarcinoma cell line, Immunogenetics, 56, 617, 10.1007/s00251-004-0733-7 Shiroishi, 2006, Structural basis for recognition of the nonclassical MHC molecule HLA-G by the leukocyte Ig-like receptor B2 (LILRB2/LIR2/ILT4/CD85d), Proc Natl Acad Sci U S A, 103, 16412, 10.1073/pnas.0605228103 Blobel, 1975, Transfer of proteins across membranes. I. Presence of proteolytically processed and unprocessed nascent immunoglobulin light chains on membrane-bound ribosomes of murine myeloma, J Cell Biol, 67, 835, 10.1083/jcb.67.3.835 Paetzel, 1998, Crystal structure of a bacterial signal peptidase in complex with a beta-lactam inhibitor, Nature, 396, 186, 10.1038/24196 Lemberg, 2001, Intramembrane proteolysis of signal peptides: an essential step in the generation of HLA-E epitopes, J Immunol, 167, 6441, 10.4049/jimmunol.167.11.6441 Neefjes, 1993, Cell biology of antigen presentation, Curr Opin Immunol, 5, 27, 10.1016/0952-7915(93)90077-6 Shaikly, 2010, Cell bio-imaging reveals co-expression of HLA-G and HLA-E in human preimplantation embryos, Reprod Biomed Online, 20, 223, 10.1016/j.rbmo.2009.11.008 Tripathi, 2007, The role of human leukocyte antigen E and G in HIV infection, AIDS, 21, 1395, 10.1097/QAD.0b013e32810c8bbc Nattermann, 2005, HIV-1 infection leads to increased HLA-E expression resulting in impaired function of natural killer cells, Antivir Ther, 10, 95, 10.1177/135965350501000107 Matsunami, 2002, Modulation of the leader peptide sequence of the HLA-E gene up-regulates its expression and down-regulates natural killer cell-mediated swine endothelial cell lysis, Transplantation, 73, 1582, 10.1097/00007890-200205270-00010